marginally significantP = 0.052
CF-MiPro is significantly correlated with decreased total CFU/mL (sum of aerobic and anaerobic CFU, then log 10 -transformed) for clinical samples from both subject genotypes, in a day-dependent manner for nonCF samples (day, P = 0.0014) and marginally significant in CF samples (day, P = 0.052).